Severe hypoglycemia increases dementia risk and related mortality: a nationwide, population-based cohort study
Switching medications If semaglutide side effects remain unmanageable despite dose adjustments, switching to an alternative GLP-1 receptor agonist or to tirzepatide may be appropriate
CJC-1295 No DAC (5mg Vials x 10): Also biochemically classified as Modified GRF (1-29), this compound is a synthetic 29-amino-acid analog representing the fully functional biolytic fragment of endogenous GHRH, selectively optimized with four amino acid substitutions to resist rapid enzymatic cleaving by dipeptidyl peptidase-4 (DPP-4)
Gullaksen, L
Here is link to study: a1c reduction, weight benefits, lower side effectsonce it goes PO (for needle averse) & cost lowered (maybe?) - I see it utilized even more wondering how plans are building this inside their MLR strategy The metformin-to-GLP-1 shift in first-line prescribing is one of the fastest I have seen across any therapy class
Note: All access is provided strictly on a Named Patient Import Basis and for personal use only, in accordance with Indian regulatory guidelines